GO:0061436 establishment of skin barrier: Barrier Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061436 establishment of skin barrier describes the biological process that builds the functional epithelial barrier of the skin and limits its permeability.
• The barrier is a layered system: cornified envelope proteins such as FLG and LOR, intercellular lipids including ceramides, tight junctions, and an acidic surface pH work together to block water loss and pathogen entry.
• Disruption of this process is central to atopic dermatitis, contact dermatitis, ichthyosis vulgaris, and allergic sensitization.
• FLG loss-of-function variants are the best-characterized genetic cause of impaired skin barrier establishment and are linked to early-onset atopic dermatitis.
• Skin pH, the microbiome, and ceramide composition are measurable biomarkers of barrier status and are used to phenotype dermatitis models.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell and mouse models allow causal testing of barrier genes such as FLG, LOR, and TGM1.
Description
GO:0061436 establishment of skin barrier is a Gene Ontology biological process term defined as the establishment of the epithelial barrier, the functional barrier in the skin that limits its permeability. In practical terms, it covers the developmental and homeostatic programs that assemble the outermost epidermal layers into a semi-permeable, protective interface between the organism and its environment. This process is not a single event but a coordinated sequence involving keratinocyte differentiation, lipid deposition, cornified envelope formation, and tight junction assembly. Researchers study it because the skin barrier is the first line of defense against water loss, allergens, irritants, and microbes, and its failure is a hallmark of common inflammatory skin diseases. The term is therefore a hub for dermatology, immunology, and epithelial biology, linking genetics, lipid metabolism, and microbiome interactions. Because barrier status can be quantified by transepidermal water loss, pH, ceramide profiling, and epidermal biomarker expression, GO:0061436 is also a tractable target for experimental modeling and therapeutic development.
establishment of skin barrier At A Glance
| GO ID | GO:0061436 |
|---|---|
| GO term | establishment of skin barrier |
| Ontology | biological_process |
| Synonym | epithelial barrier development; establishment of epithelial barrier; skin barrier development |
| Major function | Establishment of the epithelial barrier in the skin that limits permeability |
| Related anatomy | Epidermis, stratum corneum, cornified envelope, tight junctions |
| Key molecules | FLG, LOR, TGM1, ceramides, filaggrin breakdown products |
| Associated diseases | Atopic dermatitis, contact dermatitis, ichthyosis vulgaris, allergic sensitization |
| Measurable readouts | Transepidermal water loss, skin pH, ceramide profile, epidermal biomarkers |
What Is GO:0061436?
In our own words, GO:0061436 establishment of skin barrier refers to the set of biological processes that create and maintain the skin's functional epithelial barrier, the structure that controls permeability and separates the body from the external environment. It encompasses the differentiation of keratinocytes into corneocytes, the assembly of the cornified envelope, the secretion and organization of intercellular lipids such as ceramides, and the formation of junctional complexes that together limit water loss and exclude foreign substances.
Why Is establishment of skin barrier Important in Cell Biology?
The establishment of the skin barrier is important because it determines whether the skin can perform its primary protective function: retaining water and excluding allergens, irritants, and pathogens. When this process is defective, individuals develop dry, inflamed skin and are at increased risk of atopic dermatitis, contact dermatitis, and allergic disease. Because barrier integrity is measurable and modifiable, it is a central endpoint in dermatological research, from genetic studies of FLG to lipid-focused ceramide research and microbiome analysis.
• Defines the skin's permeability barrier, preventing excessive water loss and blocking entry of allergens and irritants.
• Its failure is a primary risk factor for atopic dermatitis and allergic sensitization.
• FLG loss-of-function mutations impair barrier establishment and cause ichthyosis vulgaris and early-onset atopic dermatitis.
• Ceramide composition and skin pH are direct biochemical indicators of barrier function and are altered in dermatitis.
• The skin microbiome interacts with barrier status, and dysbiosis is associated with atopic dermatitis.
• Barrier biomarkers in the epidermis help distinguish atopic from contact dermatitis in research settings.
• Mouse models such as DNCB-induced dermatitis allow controlled study of barrier disruption and repair.
• The process is a therapeutic target: restoring barrier lipids or pH may reduce inflammation and allergen penetration.
• It links genetics, lipid metabolism, and immunology, making it relevant across multiple research fields.
• Quantitative readouts such as transepidermal water loss make it experimentally tractable.
What Happens During establishment of skin barrier?
Keratinocyte differentiation and cornified envelope assembly
In simple terms: Skin cells mature and build a tough outer shell that acts like a brick wall.
Establishment of the skin barrier begins with the terminal differentiation of keratinocytes into corneocytes, which are reinforced by a cornified envelope composed of proteins such as filaggrin (FLG), loricrin (LOR), and transglutaminase-crosslinked substrates. This protein scaffold provides mechanical resilience and serves as a platform for lipid attachment, and its integrity is essential for limiting permeability. Defects in this step, as seen with FLG loss-of-function, lead to a fragile barrier and increased allergen penetration.
Intercellular lipid deposition and ceramide organization
In simple terms: Fats are laid down between the skin cells to seal the gaps, like mortar between bricks.
After cornified envelope formation, intercellular lipids, especially ceramides, are secreted into the extracellular space of the stratum corneum and organized into lamellar structures that restrict water movement. Ceramide composition and chain length are critical for barrier function, and altered ceramide profiles are observed in atopic dermatitis and other barrier disorders. This lipid matrix is a key determinant of transepidermal water loss and is a target of barrier-repair strategies.
Tight junction formation and junctional sealing
In simple terms: Cells link together with molecular zippers to close the spaces between them.
Tight junctions between keratinocytes in the granular layer form a paracellular seal that complements the cornified envelope and lipid barrier. These junctions regulate the movement of ions and solutes and contribute to the skin's permeability barrier, and their components are part of the broader epithelial barrier program. Disruption of junctional complexes can increase permeability and is implicated in inflammatory skin disease.
Acidification of the skin surface and pH-dependent enzyme activity
In simple terms: The skin surface becomes slightly acidic, which helps enzymes work and keeps harmful microbes in check.
The establishment of a functional skin barrier includes the development of an acidic surface pH, which is required for optimal activity of lipid-processing enzymes and for antimicrobial defense. Skin pH influences ceramide metabolism, barrier repair, and microbial colonization, and an elevated pH is associated with impaired barrier function in dermatitis. This acidification is therefore an integral part of barrier establishment and maintenance.
Microbiome interaction and barrier maturation
In simple terms: Helpful bacteria on the skin interact with the barrier and help keep it healthy.
The skin microbiome interacts with the developing barrier, and microbial communities influence barrier function and immune education. In atopic dermatitis, dysbiosis, particularly increased Staphylococcus aureus, is associated with barrier disruption and inflammation. Barrier establishment therefore includes the acquisition of a balanced microbiome that supports rather than compromises the epithelial barrier.
Key Genes Involved in GO:0061436 establishment of skin barrier
The following genes and proteins are central to the establishment and maintenance of the skin barrier, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FLG | Filaggrin; aggregates keratin filaments and contributes to cornified envelope and natural moisturizing factor | Loss-of-function variants cause ichthyosis vulgaris and predispose to atopic dermatitis |
| LOR | Loricrin; major cornified envelope protein | Marker of terminal differentiation and barrier integrity |
| TGM1 | Transglutaminase 1; crosslinks cornified envelope proteins | Mutations cause autosomal recessive congenital ichthyosis |
| SPINK5 | Serine protease inhibitor; regulates desquamation and barrier protease activity | Linked to Netherton syndrome and barrier dysfunction |
| KLK7 | Kallikrein-related peptidase 7; involved in desquamation | Protease activity affects barrier thickness and permeability |
| CERS3 | Ceramide synthase 3; synthesizes long-chain ceramides in skin | Ceramide deficiency impairs barrier and is studied in dermatitis |
| ABCA12 | Lipid transporter; required for lamellar body formation | Mutations cause harlequin ichthyosis and severe barrier defects |
| CLDN1 | Claudin-1; tight junction protein | Tight junction integrity contributes to barrier sealing |
| OCLN | Occludin; tight junction component | Part of junctional barrier in epidermis |
| CDSN | Corneodesmosin; desmosomal component of corneocytes | Affects desquamation and barrier cohesion |
| DSC1 | Desmocollin 1; desmosomal cadherin | Cell-cell adhesion in epidermis |
| DSG1 | Desmoglein 1; desmosomal cadherin | Barrier and adhesion; linked to severe dermatitis |
| NLRP3 | Inflammasome sensor; responds to barrier disruption | Inflammation driven by barrier breach |
| IL1B | Interleukin 1 beta; cytokine induced by barrier damage | Marker of barrier-related inflammation |
| TSLP | Thymic stromal lymphopoietin; epithelial cytokine | Released upon barrier disruption; drives Th2 responses |
| S100A7 | Antimicrobial peptide and epidermal biomarker | Measured in atopic and contact dermatitis studies |
| PI3 | Peptidase inhibitor 3; antimicrobial and barrier-related | Epidermal biomarker of barrier status |
| KRT16 | Keratin 16; induced in activated epidermis | Marker of epidermal stress and barrier perturbation |
How Is establishment of skin barrier Regulated?
The establishment of the skin barrier is regulated at multiple levels. Transcriptional control of differentiation genes such as FLG and LOR is coordinated with cornified envelope assembly. Proteolytic processing by kallikreins and their inhibitors, including SPINK5, regulates desquamation and barrier thickness. Lipid metabolism, particularly ceramide synthesis by CERS3 and lipid transport by ABCA12, controls the intercellular lipid matrix. Skin surface pH modulates enzyme activity and microbial colonization, and an acidic pH supports barrier homeostasis. Inflammatory cytokines such as TSLP and IL1B can be induced by barrier disruption and further alter barrier gene expression, creating a feedback loop between barrier status and immune activation. The microbiome also influences barrier regulation, with dysbiosis associated with impaired barrier function in atopic dermatitis.
establishment of skin barrier and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLG | Ichthyosis vulgaris and atopic dermatitis; impaired barrier and allergen penetration | FLG knockout keratinocytes or mouse models; point-mutation knock-in of common variants |
| TGM1 | Autosomal recessive congenital ichthyosis; defective cornified envelope | TGM1 knockout or point-mutation cell models; skin equivalent models |
| ABCA12 | Harlequin ichthyosis; defective lipid transport and lamellar bodies | ABCA12 knockout keratinocytes; lipid profiling |
| CERS3 | Ceramide deficiency and barrier dysfunction | CERS3 knockout or overexpression models; ceramide profiling |
| SPINK5 | Netherton syndrome; protease dysregulation and barrier failure | SPINK5 knockout or point-mutation models; protease activity assays |
Atopic dermatitis and allergic sensitization
Atopic dermatitis is a chronic inflammatory skin disease in which impaired establishment and maintenance of the skin barrier is a central pathophysiological feature. FLG loss-of-function variants are strongly associated with early-onset atopic dermatitis and increased risk of allergic sensitization, supporting the concept that barrier failure precedes and promotes allergic inflammation. Barrier disruption allows allergens and irritants to penetrate, triggering cytokine release including TSLP and IL1B, which drive Th2-type inflammation. Skin microbiome dysbiosis, particularly Staphylococcus aureus colonization, further exacerbates barrier dysfunction and inflammation in atopic dermatitis.
Contact dermatitis and epidermal biomarkers
Contact dermatitis involves barrier perturbation and inflammation in response to irritants or allergens, and epidermal biomarkers of barrier status can help distinguish atopic from contact dermatitis in research settings. Biomarkers such as S100A7, PI3, and KRT16 reflect epidermal activation and barrier stress, and their expression patterns differ between disease subtypes. These markers are useful for phenotyping barrier-related responses in clinical and experimental studies.
Ichthyosis and genetic barrier disorders
Mutations in genes required for cornified envelope formation and lipid transport, such as TGM1 and ABCA12, cause congenital ichthyoses characterized by severe barrier defects. FLG loss-of-function also causes ichthyosis vulgaris, the most common disorder of keratinization, and is a strong genetic risk factor for atopic dermatitis. These monogenic disorders highlight the non-redundant roles of specific barrier components and provide models for studying barrier establishment.
Ceramide deficiency and barrier repair
Ceramides are essential for the skin's permeability barrier, and reduced or altered ceramide levels are observed in atopic dermatitis and other barrier-compromised states. Research into ceramide metabolism, including the role of CERS3 and ABCA12, has informed barrier-repair strategies that aim to restore lipid composition. Because ceramide profiles correlate with transepidermal water loss, they serve as both a disease marker and a therapeutic target.
From establishment of skin barrier-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is FLG required for barrier establishment? | FLG knockout keratinocytes or mouse models |
| Do common FLG variants impair barrier function? | Point-mutation knock-in of FLG variants in cell or animal models |
| Can a candidate gene restore barrier lipids? | Overexpression or knock-in of ceramide synthesis genes such as CERS3 |
| How does a barrier gene affect tight junctions? | Knockout or tagged knock-in of CLDN1 or OCLN with imaging |
| What is the effect of barrier disruption on inflammation? | DNCB-induced dermatitis mouse model with cytokine profiling |
| How does the microbiome interact with barrier genes? | Germ-free or gnotobiotic models combined with barrier gene knockout |
How to Study the establishment of skin barrier Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transepidermal water loss (TEWL) | Barrier permeability to water | Assessing barrier function in dermatitis models and human skin |
| RNA sequencing | Expression of barrier-related genes and biomarkers | Phenotyping atopic vs contact dermatitis |
| Immunohistochemistry | Protein localization of FLG, LOR, and junction proteins | Evaluating barrier establishment in tissue |
| Lipidomics / mass spectrometry | Ceramide composition and lipid profile | Studying lipid barrier and repair strategies |
| Skin pH measurement | Surface acidity | Assessing barrier homeostasis and enzyme activity |
| 16S rRNA sequencing | Skin microbiome composition | Investigating dysbiosis in atopic dermatitis |
| DNCB-induced dermatitis model | Barrier disruption and inflammation | Preclinical testing of barrier-targeted interventions |
| Protease activity assays | Desquamation-related protease activity | Studying SPINK5 and KLK7 function |
Transepidermal water loss and barrier function assays
Transepidermal water loss (TEWL) is a standard non-invasive measure of skin barrier permeability and is used to quantify barrier impairment in dermatitis models and human studies. TEWL correlates with ceramide content and barrier protein expression, making it a key functional readout for GO:0061436.
Epidermal biomarker and gene expression profiling
RNA sequencing and targeted expression analysis of epidermal biomarkers such as S100A7, PI3, and KRT16 can reveal barrier status and differentiate atopic from contact dermatitis. These approaches are complemented by immunohistochemistry for FLG, LOR, and tight junction proteins to assess barrier establishment at the tissue level.
Lipidomics and ceramide profiling
Mass spectrometry-based lipidomics quantifies ceramide species and other barrier lipids, providing biochemical evidence of barrier integrity. Ceramide chain length and composition are altered in atopic dermatitis and other barrier disorders, making lipidomics a direct method to study GO:0061436.
Skin pH and microbiome analysis
Skin surface pH measurement and 16S rRNA sequencing of the skin microbiome assess two key environmental factors that influence barrier establishment. An elevated pH and dysbiosis are associated with barrier impairment, and these methods are used in both clinical and experimental studies.
How CRISPR Can Be Used to Study GO:0061436 establishment of skin barrier
Knockout
CRISPR knockout of barrier genes such as FLG, TGM1, or CERS3 in keratinocytes or mouse models allows direct testing of their requirement for establishment of the skin barrier. Knockout models can be assessed by TEWL, lipid profiling, and epidermal biomarker expression to quantify barrier impairment.
Point Mutation
Point-mutation knock-in of disease-associated variants, such as common FLG loss-of-function alleles, enables study of how specific genetic changes affect barrier establishment without confounding effects of complete gene loss. These models are valuable for genotype-phenotype correlation and for testing personalized therapeutic approaches.
Knock-in
Knock-in of reporter tags or functional domains into barrier genes allows visualization and functional dissection of proteins such as LOR or CLDN1 in the context of the endogenous locus. Tagged knock-in models support imaging and interaction studies that reveal how barrier components assemble.
Overexpression
Overexpression of barrier-related genes, such as CERS3 or ABCA12, can test whether increasing a specific component enhances barrier function or rescues defects. Overexpression models are useful for identifying rate-limiting steps in lipid deposition and cornified envelope formation.
How EDITGENE Supports establishment of skin barrier Research
Researchers studying establishment of skin barrier-related genes often need to determine whether a candidate gene is causally involved in barrier formation or maintenance, and CRISPR-based models provide a direct way to test this. EDITGENE offers a suite of services to generate and characterize such models, from knockout to knock-in and overexpression, supported by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for establishment of skin barrier research.
Frequently Asked Questions About establishment of skin barrier
What is GO:0061436 establishment of skin barrier?
GO:0061436 is a Gene Ontology biological process term defined as the establishment of the epithelial barrier, the functional barrier in the skin that limits its permeability.
What genes are involved in establishment of skin barrier?
Key genes include FLG, LOR, TGM1, SPINK5, KLK7, CERS3, ABCA12, CLDN1, OCLN, CDSN, DSC1, and DSG1, based on published literature.
Why is the skin barrier important in atopic dermatitis?
Impaired skin barrier establishment allows allergen penetration and triggers inflammation, and FLG loss-of-function is a major risk factor for atopic dermatitis.
How is skin barrier function measured?
Common methods include transepidermal water loss, skin pH measurement, ceramide profiling, and epidermal biomarker expression analysis.
What is the role of filaggrin in the skin barrier?
Filaggrin aggregates keratin filaments and contributes to the cornified envelope and natural moisturizing factor, and its loss causes ichthyosis vulgaris and predisposes to atopic dermatitis.
How do ceramides contribute to the skin barrier?
Ceramides form the intercellular lipid matrix that restricts water loss, and altered ceramide profiles are observed in atopic dermatitis and other barrier disorders.
Can CRISPR be used to study skin barrier genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of barrier genes such as FLG and CERS3.
What is the link between skin pH and barrier function?
An acidic skin surface pH supports lipid-processing enzyme activity and antimicrobial defense, and elevated pH is associated with impaired barrier function.
How does the skin microbiome affect the barrier?
The skin microbiome interacts with the barrier, and dysbiosis, particularly Staphylococcus aureus overgrowth, is associated with atopic dermatitis.
What models are used to study establishment of skin barrier?
Models include keratinocyte knockout and knock-in lines, DNCB-induced dermatitis mouse models, and skin equivalent cultures assessed by TEWL and biomarker analysis.
Conclusion
GO:0061436 establishment of skin barrier is a central biological process that builds and maintains the skin's permeability barrier through keratinocyte differentiation, cornified envelope assembly, lipid deposition, tight junction formation, and surface acidification. Its disruption is a key mechanism in atopic dermatitis, contact dermatitis, and ichthyosis, and it is a major focus of dermatological research. CRISPR-based models and quantitative barrier assays provide powerful tools to dissect the genetic and biochemical basis of this process and to evaluate therapeutic strategies.
References
- 1. Koh LF et al.. 2022. Skin microbiome of atopic dermatitis.. Allergol Int 71(1):31-39 PMID: 34838450
- 2. Yong TL et al.. 2025. Ceramides and Skin Health: New Insights.. Exp Dermatol 34(2):e70042 PMID: 39912256
- 3. Proksch E. 2018. pH in nature, humans and skin.. J Dermatol 45(9):1044-1052 PMID: 29863755
- 4. Riedl R et al.. 2023. Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model.. Int J Mol Sci 24(15) PMID: 37569701
- 5. de Boer FL et al.. 2023. Epidermal biomarkers of the skin barrier in atopic and contact dermatitis.. Contact Dermatitis 89(4):221-229 PMID: 37571977
- 6. Savva M et al.. 2024. Recent Advancements in the Atopic Dermatitis Mechanism.. Front Biosci (Landmark Ed) 29(2):84 PMID: 38420827
- 7. Stefanovic N et al.. 2024. Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives.. Ann Allergy Asthma Immunol 132(2):187-195 PMID: 37758055
